May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Macular Hard Exudates (HE) in Patients with Branch Retinal Vein Occlusion (BVO)
M. Khairallah; S. Ben Yahia; A. Ladjimi; R. Bouraoui; S. Jenzri; S. Zaouali; R. Messaoud
Author Affiliations & Notes
  • M. Khairallah
    Dept Ophthalmology, University Hospital, Monastir, Tunisia
  • S. Ben Yahia
    Dept Ophthalmology, University Hospital, Monastir, Tunisia
  • A. Ladjimi
    Dept Ophthalmology, University Hospital, Monastir, Tunisia
  • R. Bouraoui
    Dept Ophthalmology, University Hospital, Monastir, Tunisia
  • S. Jenzri
    Dept Ophthalmology, University Hospital, Monastir, Tunisia
  • S. Zaouali
    Dept Ophthalmology, University Hospital, Monastir, Tunisia
  • R. Messaoud
    Dept Ophthalmology, University Hospital, Monastir, Tunisia
  • Footnotes
    Commercial Relationships  M. Khairallah, None; S. Ben Yahia, None; A. Ladjimi, None; R. Bouraoui, None; S. Jenzri, None; S. Zaouali, None; R. Messaoud, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 4041. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Macular Hard Exudates (HE) in Patients with Branch Retinal Vein Occlusion (BVO)
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      M. Khairallah, S. Ben Yahia, A. Ladjimi, R. Bouraoui, S. Jenzri, S. Zaouali, R. Messaoud; Macular Hard Exudates (HE) in Patients with Branch Retinal Vein Occlusion (BVO) . Invest. Ophthalmol. Vis. Sci. 2003;44(13):4041.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Abstract: : Purpose: To describe the characteristics of and associated risk factors for macular HE in patients with BVO. Methods: The records of 83 patients (85 eyes) with BVO were reviewed. All patients underwent a complete ophthalmic examination, including best-corrected visual acuity and contact lens slit lamp biomicroscopic ophthalmoscopy, and fluorescein angiography. Results: Macular HE developed in 27 eyes (31.8%). They were severe in 10 of 27 eyes (37%). Foveal location of HE was observed in 6 eyes (22.2%). The presence of HE was significantly (p< 0.05) associated with diabetes, retinal macroaneurysms, and severe capillary leakage on fluorescein angiography. Conclusions: In patients with BVO, particularly those at high risk for developing HE, close follow-up and timely focal laser treatment are crucial to prevent visual loss due to the accumulation of HE in the fovea.

Keywords: lipids • macula/fovea • vascular occlusion/vascular occlusive disease 
© 2003, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2024 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept